ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fiore, A. C.
Right arrow Articles by Barner, H. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fiore, A. C.
Right arrow Articles by Barner, H. B.

The Annals of Thoracic Surgery, Vol 50, 771-775, Copyright © 1990 by The Society of Thoracic Surgeons


ARTICLES

Myocardial preservation using lidocaine blood cardioplegia

AC Fiore, KS Naunheim, J Taub, P Braun, LR McBride, DG Pennington, GC Kaiser, VL Willman and HB Barner
Department of Surgery, St. Louis University Medical Center, MO 63110- 0250.

Prevention of ventricular fibrillation after aortic unclamping using lidocaine hydrochloride as an additive to cold potassium blood cardioplegia was studied prospectively in 46 patients undergoing elective myocardial revascularization. Patients were similar with respect to age, ventricular function, severity of coronary artery disease, cross-clamp time, completeness of revascularization, frequency of internal thoracic artery grafting, systemic temperature at the time of cross-clamp removal, and mean infusate volume and temperature. Patients receiving lidocaine blood cardioplegia (group 1, 23 patients) had a significant reduction in the incidence of ventricular fibrillation (22% versus 74%; p less than 0.0005) and in the mean number of cardioversion attempts required to defibrillate the heart (0.5 +/- 1.3 versus 1.9 +/- 0.97; p less than 0.0005) after cross-clamp removal compared with controls (group 2, 23 patients). There were no differences between the two groups postoperatively with regard to cardiac enzyme release, hemodynamic measurements, or clinical outcome. Patients receiving lidocaine blood cardioplegia tended to have a lower incidence of new postoperative atrial fibrillation (9% versus 26%). Ventricular function was preserved equally in both groups. We conclude that lidocaine is a safe additive to potassium blood cardioplegia and significantly reduces the incidence of ventricular fibrillation after aortic unclamping.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
J. C. Cleveland Jr, D. R. Meldrum, R. T. Rowland, A. Banerjee, and A. H. Harken
Optimal Myocardial Preservation: Cooling, Cardioplegia, and Conditioning
Ann. Thorac. Surg., February 1, 1996; 61(2): 760 - 768.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
E. Ovrum, G. Tangen, E. A. Holen, M.-A. L. Ringdal, and R. Istad
Conversion of Postischemic Ventricular Fibrillation With Intraaortic Infusion of Potassium Chloride
Ann. Thorac. Surg., July 1, 1995; 60(1): 156 - 159.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1990 by The Society of Thoracic Surgeons.